None listed
Conditions
Interventions
None listed
Sponsors
Chonnam National University Bitgoeul Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who can administer Infliximab SC (subcutaneous injection) under approved indication of this drug 2) an adult patient over the age of 19 3) Those who voluntarily agreed in writing to this study 4) Among women of childbearing age, appropriate contraception is performed to prevent pregnancy and Infliximab SC 5) Those who can use contraception for at least six months after the final dose (the implementation of contraception is based on risks and benefits) It can be decided after discussion with a female researcher.) 5) Voluntarily for long-term follow-up, including access to all medical records Patient by (signed ICF)
Exclusion criteria
Exclusion criteria: 1) A person who is prohibited from being administered as specified in the product description of this drug 2) A person who intends to use Infliximab SC for purposes other than permission 3) a pregnant woman or nursing woman 4) Patients who are unfit to participate in research by researcher's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| EQ-5D-5L;Work productivity and activity impairment questionnaire(WPAI);Adverse event of special interest, AESI;trough level;Anti-drug antibody(ADA);Drug survival;Primary response rate;Sustainable Clinical response rate;Ankylosing Spondylitis Disease Activity Score(ASDAS) ;Visual Analog Scale;ASAS-HI | — |
Countries
Korea, Republic of
Contacts
Public ContactShinseok Lee
Chonnam National University Hospital
Outcome results
None listed